WCN26-5508 DUAL RENAL IMMUNE-RELATED ADVERSE EVENTS AFTER PEMBROLIZUMAB: ACUTE INTERSTITIAL NEPHRITIS AND TYPE 4 RENAL TUBULAR ACIDOSIS—A CASE REPORT

Read full text Summarise with VIRAT
Authors: Pratya Pumuthaivirat, Suppalux Limpiwattakee, Kritrawin Saranyanurak, Piyarat Limpawittayakul, Suchin Worawichawong, Tanatorn Siripoon, Patthraphorn Chalermsuk
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Immune checkpoint inhibitors (ICIs), pembrolizumab, are known to induce renal immune-related adverse events (irAEs), most frequently presenting as acute interstitial nephritis (AIN). However, Type 4 renal tubular acidosis (RTA) resulting from immune-mediated hypoaldosteronism is a less commonly reported complication.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Acute Kidney Injury Research Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105966–105966
Publication date
25 March 2026
Language
EN